دورية أكاديمية

Veterinary deworming agent-induced toxic optic neuropathy: a case report.

التفاصيل البيبلوغرافية
العنوان: Veterinary deworming agent-induced toxic optic neuropathy: a case report.
المؤلفون: Qin L; Department of Ophthalmology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510000, China., Wang K; The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, 510120, Guangdong, China., Ou Y; Department of Ophthalmology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510000, China., Pang L; Department of Ophthalmology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510000, China. pl_ophthalmology@163.com.
المصدر: BMC ophthalmology [BMC Ophthalmol] 2023 Aug 16; Vol. 23 (1), pp. 357. Date of Electronic Publication: 2023 Aug 16.
نوع المنشور: Case Reports; Journal Article
اللغة: English
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967802 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2415 (Electronic) Linking ISSN: 14712415 NLM ISO Abbreviation: BMC Ophthalmol Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : BioMed Central, [2001-
مواضيع طبية MeSH: Toxic Optic Neuropathy* , Anti-Infective Agents*, Male ; Humans ; Adult ; Bithionol ; Triclabendazole ; Vision Disorders
مستخلص: Background: Veterinary antiparasitic drugs are widely used in countries and regions in which parasitic diseases are endemic, which leads to the risk of accidental ingestion and poisoning in humans.  CASE PRESENTATION: A 40-year-old male patient with a history of cirrhosis sought medical attention on November 25, 2021, due to progressive vision loss. He had previously taken triclabendazole and bithionol and was diagnosed with toxic optic neuropathy on examination. Steroid, neurotonic, and high-pressure oxygen therapy were ineffective.
Conclusions: Triclabendazole and bithionol have potential risk of optic neurotoxicity and should be considered for enhanced supervision and warning labels.
(© 2023. BioMed Central Ltd., part of Springer Nature.)
References: Expert Rev Anti Infect Ther. 2021 Jul;19(7):817-823. (PMID: 33267701)
Nucleic Acids Res. 2021 Jan 8;49(D1):D1388-D1395. (PMID: 33151290)
Case Rep Ophthalmol Med. 2021 May 21;2021:4832965. (PMID: 34094608)
JAMA Ophthalmol. 2015 Jun;133(6):718-20. (PMID: 25742635)
BMC Ophthalmol. 2021 Mar 31;21(1):158. (PMID: 33789597)
Kisaengchunghak Chapchi. 1982 Jun;20(1):49-52. (PMID: 12902700)
Indian J Ophthalmol. 2019 Oct;67(10):1768-1771. (PMID: 31546560)
Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. (PMID: 29126136)
Hepatology. 1991 Dec;14(6):1066-9. (PMID: 1959855)
Am J Trop Med Hyg. 1970 Nov;19(6):940-2. (PMID: 5493054)
J Trop Med Hyg. 1988 Oct;91(5):240-4. (PMID: 3184244)
Clin Case Rep. 2021 Dec 09;9(12):e05157. (PMID: 34938546)
Trans R Soc Trop Med Hyg. 2019 Dec 1;113(12):797-804. (PMID: 31638149)
Am J Trop Med Hyg. 1967 Sep;16(5):585-90. (PMID: 6053526)
فهرسة مساهمة: Keywords: Bithionol; Case report; Ocular; Optic neurotoxicity; Toxic optic neuropathy; Triclabendazole; Vision
المشرفين على المادة: AMT77LS62O (Bithionol)
4784C8E03O (Triclabendazole)
0 (Anti-Infective Agents)
تواريخ الأحداث: Date Created: 20230815 Date Completed: 20230817 Latest Revision: 20231123
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC10428528
DOI: 10.1186/s12886-023-03097-8
PMID: 37582712
قاعدة البيانات: MEDLINE
الوصف
تدمد:1471-2415
DOI:10.1186/s12886-023-03097-8